 | $45.67 Million in Sales Expected for Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) This Quarter
americanbankingnews.com - April 10 at 3:00 AM |
| Zacks: Brokerages Anticipate Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) to Post $0.72 EPS
americanbankingnews.com - April 8 at 12:16 PM |
| Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Expected to Announce Quarterly Sales of $45.67 Million
americanbankingnews.com - March 24 at 9:56 AM |
 | EGRX Mar 2021 45.000 call
in.finance.yahoo.com - March 20 at 12:58 PM |
| EGRX Mar 2021 50.000 put
in.finance.yahoo.com - March 20 at 12:58 PM |
| EGRX Jun 2021 50.000 put
in.finance.yahoo.com - March 20 at 7:58 AM |
| EGRX Mar 2021 65.000 call
in.finance.yahoo.com - March 20 at 7:58 AM |
| Is Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Trading At A 21% Discount?
finance.yahoo.com - March 3 at 9:06 AM |
 | Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript
msn.com - March 2 at 2:07 PM |
| Eagle Pharmaceuticals (EGRX) Beats Q4 Earnings Estimates
finance.yahoo.com - March 2 at 9:06 AM |
| Earnings Preview: Eagle Pharmaceuticals
finance.yahoo.com - March 1 at 1:55 PM |
| Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021
finance.yahoo.com - February 22 at 6:16 PM |
|
 | FDA CRL
benzinga.com - February 2 at 9:34 AM |
| FDA Rejects Eagle Pharma's Vasopressin Application
msn.com - February 2 at 9:34 AM |
 | Eagle Pharma Receives CRL From FDA On Vasopressin
nasdaq.com - February 2 at 9:34 AM |
| Eagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin Trial
finance.yahoo.com - February 2 at 9:34 AM |
| Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed
finance.yahoo.com - February 1 at 8:39 AM |
| Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 Concerns
finance.yahoo.com - January 11 at 9:16 AM |
| Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 6:28 PM |
| Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
finance.yahoo.com - January 3 at 1:02 PM |
| Is EGRX A Good Stock To Buy Now?
finance.yahoo.com - December 15 at 11:05 PM |
| Eagle Pharmaceuticals’ Presentation at Piper Sandler 32nd Annual Virtual Healthcare Conference Available for Viewing
finance.yahoo.com - November 23 at 10:54 AM |
| Results: Eagle Pharmaceuticals, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
nasdaq.com - November 4 at 8:38 AM |
| Eagle Pharmaceuticals, Inc. Just Beat EPS By 2,450%: Here's What Analysts Think Will Happen Next
finance.yahoo.com - November 4 at 8:38 AM |
 | Eagle Pharmaceuticals up 8% on Q3 beat
seekingalpha.com - November 2 at 1:56 PM |
| Eagle Pharmaceuticals EPS beats by $0.88, beats on revenue
seekingalpha.com - November 2 at 8:55 AM |
| Eagle Pharmaceuticals Reports Third Quarter 2020 Results
finance.yahoo.com - November 2 at 8:55 AM |
| Eagle Pharmaceuticals (EGRX) Beats Q3 Earnings and Revenue Estimates
finance.yahoo.com - November 2 at 8:55 AM |
| Eagle Pharmaceuticals to Discuss Third Quarter 2020 Financial Results on November 2, 2020
finance.yahoo.com - October 26 at 6:39 PM |
| Eagle Pharmaceuticals, Inc. (1E6.F)
in.finance.yahoo.com - October 11 at 6:40 PM |
| Eagle Pharmaceuticals Inc. Regi (1E6.SG)
au.finance.yahoo.com - October 9 at 9:42 AM |
| Companies Are Starting to Buy Back Stock Again. Why That’s Good News.
finance.yahoo.com - September 24 at 12:34 PM |
|
| Eagle Pharmaceuticals commences $25M accelerated share repurchase
seekingalpha.com - September 24 at 7:29 AM |
 | Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute (“RTD”) Formulation, with Launch Expected in January 2021
businesswire.com - September 24 at 1:08 AM |
| Eagle Pharma's TREAKISYM RTD formulation OK'd in Japan; launch expected in January 2021
seekingalpha.com - September 23 at 9:53 AM |
| Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute ("RTD") Formulation, with Launch Expected in January 2021
finance.yahoo.com - September 23 at 9:52 AM |
| Eagle Pharmaceuticals (EGRX) Has Fallen 38% in Last One Year, Underperforms Market
finance.yahoo.com - September 9 at 2:24 PM |
| Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare Conferences
finance.yahoo.com - September 8 at 8:04 AM |
| Eagle Pharmaceuticals Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimer’s Disease
finance.yahoo.com - August 19 at 8:20 AM |
| More on Eagle Pharma Q2 earnings
seekingalpha.com - August 10 at 6:27 PM |
| Eagle Pharmaceuticals Inc (EGRX) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 10 at 6:27 PM |
| Recap: Eagle Pharmaceuticals Q2 Earnings
finance.yahoo.com - August 10 at 1:26 PM |
| Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Top Estimates
finance.yahoo.com - August 10 at 1:26 PM |
| Eagle Pharmaceuticals EPS beats by $0.34, misses on revenue
seekingalpha.com - August 10 at 8:26 AM |
| Eagle Pharmaceuticals Reports Second Quarter 2020 Results
finance.yahoo.com - August 10 at 8:26 AM |
| Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020
finance.yahoo.com - August 3 at 7:50 PM |
| Is Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
finance.yahoo.com - July 17 at 1:36 PM |
| Is Eagle Pharmaceuticals, Inc.'s (NASDAQ:EGRX) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
finance.yahoo.com - July 17 at 1:36 PM |
| CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection)
finance.yahoo.com - July 9 at 2:41 PM |
| The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus
finance.yahoo.com - July 6 at 12:36 PM |
